![]()
Daily Range
Daily RangeToday's Low
₹ 1,469.05
Today's High
₹ 1,506.60
![]()
52 Weeks Range
52 Weeks Low
₹ 852.00
52 Weeks High
₹ 1,180.10
![]()
Momentum of the Stock
Momentum of the Stock ![]()
Neutral
Neutral![]()
Circuit Limit
Lower
₹ 1,324.85
Upper
₹ 1,619.25
![]()
Financials Strength Score
Financials Strength Score Piotroski Score
![]()
Company Profile
Cipla Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India, the United States, South Africa, and internationally. The company offers active pharmaceutical ingredients; and formulations in various therapeutic areas, such as MI, angina, heart failure, hypertension, arrhythmia, lipid abnormalities and diabetes, obesity, HIV, respiratory, urology, oncology, cardio-metabolism, child health, infectious diseases and critical care, hepatitis, women's health, ophthalmology, and neuro psychiatry. It also provides respiratory products, including inhalers and nasal sprays, as well as other dosage forms consists of injectables and biosimilars. Cipla Limited has collaboration with CSIR-Indian Institute of Chemical Technology for the development of medication for the treatment of COVID-19; partnership with Karwa Ltd. for the commercialization of antibody detection kits for COVID-19; partnership with the Premier Medical Corporation Private Limited for the commercialization of the rapid antigen test kits for COVID-19; licensing agreement with Merck & Co., Inc. for the manufacturing and distribution of Molnupiravir, an investigational oral antiviral drug; license agreement with Eli Lilly and Company for the manufacture and commercialization of the drug baricitinib for Covid-19 indication; and collaborations with Dr. Reddy's Laboratories Ltd, Sun Pharmaceutical Industries Limited, Emcure Pharmaceuticals Limited, and Torrent Pharmaceuticals Limited for the clinical trial of the investigational oral anti-viral drug Molnupiravir. The company was incorporated in 1935 and is headquartered in Mumbai, India.
![]()
Companies under the same Group
Companies under the same Group
No Data Found
![]()
Key Metrics
Key MetricsStandalone
Consolidated
No of shares Outstanding
80.8 Cr.
EPS-TTM
₹55.41
Face Value
₹2.00
Book Value
₹351.18
Net Asset Value
₹289.24
ROE
12.85%
ROA
10.19%
ROCE
18.19%
Dividend Yield
0.88%
Total Debt
₹ 0.0 Cr.
Sales Growth
4.55%
PAT Growth
10.78%
Financials
| Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 16,805.1 | 14,710.8 | 13,181.0 | 11,703.8 | 12,424.6 | 10,814.1 | 8,735.6 | 8,841.2 | 7,591.3 | 5,652.0 | 6,784.0 | 5,056.8 | 4,443.1 | 5,924.0 | 5,204.7 | 3,834.1 | 2,948.2 |
| Total Non-Current Assets | 11,731.8 | 11,924.8 | 11,627.7 | 11,716.6 | 11,335.3 | 11,858.8 | 12,064.3 | 12,208.3 | 9,689.5 | 9,039.6 | 5,537.3 | 4,819.6 | 4,618.9 | 2,696.4 | 2,359.8 | 1,898.5 | 1,465.3 |
| Total Assets | 29,006.7 | 26,652.3 | 24,837.2 | 23,422.8 | 23,761.9 | 22,672.9 | 20,868.9 | 21,049.5 | 17,280.8 | 14,691.6 | 12,321.3 | 9,876.4 | 9,062.0 | 8,620.4 | 7,564.6 | 5,732.6 | 4,413.5 |
| Total Current Liabilities | 5,033.3 | 4,912.9 | 4,591.1 | 4,393.1 | 3,771.5 | 3,832.2 | 3,373.7 | 7,776.1 | 3,881.1 | 2,563.6 | 2,277.6 | 1,413.2 | 1,698.5 | 2,525.6 | 2,112.4 | 1,287.8 | 941.3 |
| Total Non-Current Liabilities | 183.5 | 621.7 | 1,660.1 | 2,972.4 | 4,646.2 | 4,259.1 | 4,513.4 | 1,407.1 | 2,417.7 | 2,028.1 | 1,025.0 | 824.3 | 697.3 | 184.2 | 1,104.4 | 689.6 | 236.2 |
| Shareholder's Funds | 23,407.8 | 20,841.7 | 18,326.5 | 15,763.0 | 15,012.3 | 14,229.2 | 12,543.7 | 11,516.2 | 10,801.5 | 10,050.4 | 9,018.7 | 7,638.9 | 6,666.1 | 5,910.6 | 4,347.8 | 3,755.2 | 3,236.0 |
| Total Liabilities | 29,006.7 | 26,652.3 | 24,837.2 | 23,422.8 | 23,761.9 | 22,672.9 | 20,868.9 | 21,049.5 | 17,280.8 | 14,691.6 | 12,321.3 | 9,876.4 | 9,062.0 | 8,620.4 | 7,564.6 | 5,732.6 | 4,413.5 |
![]()
Financial Statement Analysis
Price to BV
The Industry Price to BV stands at 7.44, vs the Price to BV of 4.82, which results in a Negative aspect.
Debt to Equity Ratio
The Industry Debt to Equity Ratio stands at 0.23, vs the Debt to Equity Ratio of 0.18, which results in a Positive aspect.
Current Ratio
The Industry Current Ratio stands at 2.30, vs the Current Ratio of 2.66, which results in a Positive aspect.
Quick Ratio
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 1.67, which results in a Positive aspect.
| Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Income | 22,753.1 | 21,763.3 | 19,159.6 | 17,132.0 | 16,362.4 | 15,155.7 | 14,394.3 | 13,594.9 | 11,345.4 | 10,173.4 | 8,279.3 | 7,020.7 | 6,323.8 | 5,359.5 | 4,960.6 | 4,010.4 | 3,438.2 |
| Total Expenditure | 17,762.8 | 17,251.4 | 14,910.9 | 13,951.2 | 13,265.1 | 12,329.3 | 11,918.5 | 11,115.2 | 9,183.7 | 8,040.3 | 6,081.5 | 5,361.9 | 4,954.6 | 4,286.6 | 4,215.6 | 3,377.9 | 2,746.3 |
| Operating Profit(Excl OI) | 5,502.4 | 4,833.7 | 4,518.4 | 3,550.2 | 3,573.9 | 3,184.0 | 2,704.5 | 2,687.9 | 2,327.3 | 2,398.4 | 2,420.0 | 1,798.4 | 1,460.9 | 1,426.5 | 1,099.5 | 971.8 | 922.3 |
| Add: Other Income | 512.1 | 321.7 | 269.8 | 369.4 | 476.6 | 357.7 | 228.7 | 208.2 | 165.6 | 265.4 | 222.1 | 139.5 | 91.7 | 353.5 | 354.5 | 339.3 | 230.4 |
| Operating Profit | 5,502.4 | 4,833.7 | 4,518.4 | 3,550.2 | 3,573.9 | 3,184.0 | 2,704.5 | 2,687.9 | 2,327.3 | 2,398.4 | 2,420.0 | 1,798.4 | 1,460.9 | 1,426.5 | 1,099.5 | 971.8 | 922.3 |
| Less: Interest | 109.5 | 106.4 | 160.7 | 197.4 | 168.4 | 114.2 | 159.4 | 206.6 | 168.3 | 145.7 | 33.9 | 38.3 | 25.1 | 28.3 | 52.2 | 17.5 | 11.2 |
| PBDT | 5,392.9 | 4,727.3 | 4,357.7 | 3,352.8 | 3,405.5 | 3,069.8 | 2,545.1 | 2,481.3 | 2,159.0 | 2,252.7 | 2,386.1 | 1,760.0 | 1,435.8 | 1,398.2 | 1,047.3 | 954.2 | 911.1 |
| Less: Depreciation Amortization | 1,172.1 | 1,052.0 | 1,067.7 | 1,174.7 | 1,326.3 | 1,322.8 | 1,322.9 | 754.2 | 504.7 | 372.6 | 330.5 | 312.2 | 273.3 | 167.1 | 151.8 | 116.3 | 103.4 |
| PBT & Exceptional Items | 4,220.8 | 3,675.4 | 3,290.1 | 2,178.2 | 2,079.1 | 1,747.0 | 1,222.2 | 1,727.0 | 1,654.3 | 1,880.0 | 2,055.6 | 1,447.8 | 1,162.5 | 1,231.1 | 895.5 | 838.0 | 807.7 |
| Less: Exceptional Income Expenses | -182.4 | -182.1 | 0.0 | 0.0 | 0.0 | -77.5 | 0.0 | 0.0 | 0.0 | 0.0 | 39.8 | 0.0 | 0.0 | 95.0 | 0.0 | 0.0 | 0.0 |
| Profit Before Tax | 4,038.4 | 3,493.3 | 3,290.1 | 2,178.2 | 2,079.1 | 1,669.5 | 1,222.2 | 1,727.0 | 1,654.3 | 1,880.0 | 2,095.4 | 1,447.8 | 1,162.5 | 1,326.1 | 895.5 | 838.0 | 807.7 |
| Less: Taxation | 1,202.9 | 933.8 | 888.8 | 631.2 | 569.5 | 250.1 | 179.8 | 331.6 | 400.0 | 463.4 | 544.3 | 306.5 | 195.2 | 243.5 | 124.5 | 136.9 | 140.0 |
| Profit After Tax | 2,835.5 | 2,559.5 | 2,401.3 | 1,547.0 | 1,509.6 | 1,419.4 | 1,042.4 | 1,395.4 | 1,254.2 | 1,416.7 | 1,551.1 | 1,141.3 | 967.3 | 1,082.6 | 771.0 | 701.0 | 667.8 |
| Earnings Per Share | 34.7 | 31.2 | 29.8 | 19.2 | 19.0 | 17.5 | 12.5 | 16.9 | 14.7 | 17.3 | 19.2 | 14.3 | 12.3 | 13.5 | 9.9 | 9.0 | 8.6 |
![]()
Financial Statement Analysis
Dividend Yield
The Industry Dividend Yield stands at 0.54, vs the Dividend Yield of 0.78, which results in a Positive aspect.
PE Ratio
The Industry PE Ratio stands at 48.79, vs the PE Ratio of 31.11, which results in a Negative aspect.
PAT Growth
The Industry PAT Growth stands at 30.72, vs the PAT Growth of 2.48, which results in a Negative aspect.
PAT Margin
The Industry PAT Margin stands at 9.78, vs the PAT Margin of 5.70, which results in a Negative aspect.
| Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 | FY 2013 | FY 2012 | FY 2011 | FY 2010 | FY 2009 | FY 2008 | FY 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profit Before Tax | 4,220.8 | 3,675.4 | 3,290.1 | 2,178.2 | 2,079.1 | 1,669.5 | 1,222.2 | 1,727.0 | 1,654.3 | 1,880.0 | 2,095.4 | 1,447.8 | 1,162.5 | 1,326.1 | 896.8 | 838.0 | 807.7 |
| Tax Paid | -1,301.9 | -1,139.5 | -1,037.4 | -848.3 | -593.2 | -722.0 | -450.3 | -507.7 | -392.3 | -308.3 | -461.7 | -331.5 | -264.2 | -255.8 | -64.8 | -171.0 | -93.4 |
| Adjustment | 878.2 | 967.5 | 1,130.9 | 1,365.5 | 1,268.8 | 1,293.8 | 1,374.4 | 950.9 | 630.1 | 552.8 | 283.8 | 396.7 | 288.8 | 146.5 | 252.6 | 104.5 | 48.2 |
| Changes In Working Capital | 4,220.8 | 3,675.4 | 3,290.1 | 2,178.2 | 2,079.1 | 1,669.5 | 1,222.2 | 1,727.0 | 1,654.3 | 1,880.0 | 2,095.4 | 1,447.8 | 1,162.5 | 1,326.1 | 896.8 | 838.0 | 807.7 |
| Cash Flow after changes in Working Capital | 4,539.5 | 4,465.4 | 4,792.6 | 3,916.7 | 2,284.4 | 2,184.8 | 2,832.0 | 2,248.5 | 1,565.7 | 1,871.6 | 1,859.4 | 2,044.2 | 1,289.3 | 1,298.8 | 440.9 | 538.0 | 427.4 |
| Cash Flow from Operating Activities | 3,237.7 | 3,325.9 | 3,755.2 | 3,068.5 | 1,691.1 | 1,462.8 | 2,381.8 | 1,740.8 | 1,173.4 | 1,563.3 | 1,397.7 | 1,712.8 | 1,025.1 | 1,043.0 | 374.8 | 367.0 | 333.9 |
| Cash Flow from Investing Activities | -2,388.5 | -1,871.9 | -2,387.2 | 104.0 | -1,668.7 | -854.0 | -1,310.2 | -4,522.6 | -941.2 | -1,249.9 | -2,062.9 | -965.1 | -908.4 | -562.8 | -580.1 | -674.4 | -484.7 |
| Cash Flow from Financing Activities | -958.3 | -1,599.8 | -1,239.5 | -2,948.8 | -348.7 | -385.5 | -1,325.7 | 3,104.1 | 164.8 | -265.6 | 717.8 | -753.2 | -82.8 | -471.6 | 178.9 | 254.8 | 238.6 |
| Net Cash Inflow / Outflow | -109.2 | -145.8 | 128.5 | 223.7 | -326.3 | 223.3 | -254.1 | 322.2 | 397.1 | 47.8 | 52.6 | -5.5 | 33.9 | 8.7 | -26.3 | -52.6 | 87.8 |
| Opening Cash & Cash Equivalents | 658.1 | 790.4 | 649.1 | 508.4 | 853.5 | 610.4 | 858.2 | 545.8 | 175.8 | 143.0 | 90.5 | 96.0 | 62.1 | 53.4 | 79.7 | 132.3 | 44.5 |
| Closing Cash & Cash Equivalent | 561.3 | 658.1 | 790.4 | 742.4 | 508.4 | 853.5 | 610.4 | 858.2 | 564.3 | 175.8 | 143.0 | 90.5 | 96.0 | 62.1 | 53.4 | 79.7 | 132.3 |
![]()
Financial Statement Analysis
PCF RATIO
The Industry PCF RATIO stands at 24.37, vs the PCF RATIO of 11.11, which results in a Negative aspect.
PFCF Ratio
The Industry PFCF Ratio stands at 27.34, vs the PFCF Ratio of 16.88, which results in a Negative aspect.
| Particulars | Sep 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | Dec 2020 | Sep 2020 | Jun 2020 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Sales | 70,510.2 | 66,038.1 | 66,781.5 | 63,288.9 | 57,393.0 | 58,100.9 | 58,285.4 | 53,751.9 | 52,603.3 | 54,788.6 | 55,198.0 | 55,043.5 | 46,064.5 | 51,686.9 | 50,382.9 | 43,461.6 | 43,761.9 |
| Total Income | 72,416.3 | 67,884.4 | 68,544.7 | 64,651.8 | 58,739.3 | 59,245.3 | 59,514.9 | 54,786.2 | 53,243.5 | 55,701.5 | 55,804.7 | 55,692.8 | 46,665.8 | 52,556.3 | 50,917.6 | 44,116.1 | 44,693.7 |
| Total Expenditure | 51,654.3 | 48,562.8 | 49,444.0 | 48,349.8 | 45,655.6 | 44,025.4 | 45,262.1 | 42,318.4 | 45,106.1 | 42,478.9 | 42,936.0 | 41,584.6 | 38,102.1 | 39,378.1 | 38,617.2 | 32,974.2 | 37,426.7 |
| PBIDT (Excl OI) | 18,855.9 | 17,475.3 | 17,337.5 | 14,939.1 | 11,737.4 | 14,075.5 | 13,023.3 | 11,433.5 | 7,497.2 | 12,309.7 | 12,262.0 | 13,458.9 | 7,962.4 | 12,308.8 | 11,765.7 | 10,487.4 | 6,335.2 |
| Other Income | 1,906.1 | 1,846.3 | 1,763.2 | 1,362.9 | 1,346.3 | 1,144.4 | 1,229.5 | 1,034.3 | 640.2 | 912.9 | 606.7 | 649.3 | 601.3 | 869.4 | 534.7 | 654.5 | 931.8 |
| Operating Profit | 20,762.0 | 19,321.6 | 19,100.7 | 16,302.0 | 13,083.7 | 15,219.9 | 14,252.8 | 12,467.8 | 8,137.4 | 13,222.6 | 12,868.7 | 14,108.2 | 8,563.7 | 13,178.2 | 12,300.4 | 11,141.9 | 7,267.0 |
| Interest | 154.0 | 301.0 | 258.0 | 163.9 | 343.6 | 318.2 | 255.5 | 178.1 | 181.0 | 206.8 | 380.0 | 295.7 | 274.5 | 479.2 | 393.3 | 460.0 | 530.0 |
| Exceptional Items | 0.0 | -1,948.2 | 0.0 | 0.0 | -1,824.2 | 0.0 | 0.0 | 0.0 | -575.0 | 0.0 | 0.0 | -1,246.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| PBDT | 20,608.0 | 17,072.4 | 18,842.7 | 16,138.1 | 10,915.9 | 14,901.7 | 13,997.3 | 12,289.7 | 7,381.4 | 13,015.8 | 12,488.7 | 12,566.3 | 8,289.2 | 12,699.0 | 11,907.1 | 10,681.9 | 6,737.0 |
| Depreciation | 2,717.4 | 2,334.3 | 2,900.4 | 2,392.1 | 3,462.2 | 2,721.1 | 2,993.7 | 2,544.1 | 2,903.1 | 2,474.7 | 2,530.6 | 2,611.1 | 2,851.9 | 2,484.3 | 2,650.6 | 2,689.8 | 3,458.0 |
| Profit Before Tax | 17,890.6 | 14,738.1 | 15,942.3 | 13,746.0 | 7,453.7 | 12,180.6 | 11,003.6 | 9,745.6 | 4,478.3 | 10,541.1 | 9,958.1 | 9,955.2 | 5,437.3 | 10,214.7 | 9,256.5 | 7,992.1 | 3,279.0 |
| Tax | 4,830.4 | 4,053.0 | 4,384.1 | 3,780.2 | 2,222.5 | 4,100.1 | 3,026.0 | 2,680.0 | 711.1 | 2,951.6 | 2,838.1 | 2,837.2 | 1,282.2 | 2,689.6 | 2,638.0 | 2,277.8 | 855.9 |
| Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profit After Tax | 13,060.2 | 10,685.1 | 11,558.2 | 9,965.8 | 5,231.2 | 8,080.5 | 7,977.6 | 7,065.6 | 3,767.2 | 7,589.5 | 7,120.0 | 7,118.0 | 4,155.1 | 7,525.1 | 6,618.5 | 5,714.3 | 2,423.1 |
| Net Profit | 13,060.2 | 10,685.1 | 11,558.2 | 9,965.8 | 5,231.2 | 8,080.5 | 7,977.6 | 7,065.6 | 3,767.2 | 7,589.5 | 7,120.0 | 7,118.0 | 4,155.1 | 7,525.1 | 6,618.5 | 5,714.3 | 2,423.1 |
| ADDITIONAL INFOS: | |||||||||||||||||
| Equity Capital | 1,615.1 | 1,614.7 | 1,614.7 | 1,614.5 | 1,614.3 | 1,614.3 | 1,614.0 | 1,613.8 | 1,613.6 | 1,613.6 | 1,613.3 | 1,613.2 | 1,612.9 | 1,612.9 | 1,612.7 | 1,612.5 | 1,612.5 |
| Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| EPS | 16.1 | 13.1 | 14.0 | 12.3 | 6.5 | 9.9 | 9.8 | 8.5 | 4.5 | 9.0 | 8.8 | 8.9 | 5.1 | 9.3 | 8.3 | 7.2 | 3.1 |
| Operating Profit Margin | 29.4 | 29.3 | 28.6 | 25.8 | 22.8 | 26.2 | 24.5 | 23.2 | 15.5 | 24.1 | 23.3 | 25.6 | 18.6 | 25.5 | 24.4 | 25.6 | 16.6 |
| Net Profit Margin | 18.5 | 16.2 | 17.3 | 15.7 | 9.1 | 13.9 | 13.7 | 13.1 | 7.2 | 13.9 | 12.9 | 12.9 | 9.0 | 14.6 | 13.1 | 13.1 | 5.5 |
![]()
Financial Statement Analysis
Mcap Growth
The Industry Mcap Growth stands at 19.96, vs the Mcap Growth of -20.03, which results in a Negative aspect.
Net Sales Growth
The Industry Net Sales Growth stands at 11.06, vs the Net Sales Growth of 4.70, which results in a Negative aspect.
Technicals
![]()
Pivot Levels
Pivot Levels Check Advanced Levels ![]()
| Type | Classic | Woodie | Camarilla |
|---|---|---|---|
| R4 | 1,547.15 | 1,592.59 | 1,492.70 |
| R3 | 1,533.63 | 1,528.38 | 1,482.38 |
| R2 | 1,520.12 | 1,517.49 | 1,478.93 |
| R1 | 1,496.08 | 1,490.83 | 1,475.49 |
| Pivot | 1,482.57 | 1,479.94 | 1,482.57 |
| S1 | 1,458.53 | 1,453.28 | 1,468.61 |
| S2 | 1,445.02 | 1,442.39 | 1,465.17 |
| S3 | 1,420.98 | 1,415.73 | 1,461.72 |
| S4 | 1,396.95 | 1,367.29 | 1,451.40 |
(All Values are in INR)
The Pivot level gives the user an indication about key support & resistance levels for a selected stock.
EMA & SMA Levels 
![]()
Beta
Beta 1 Day
0.26
1 Week
0.26
1 Month
0.25
![]()
Indicators
Stoch RSI
100.00
Bearish
RSI
72.01
Bearish
ROC
-1.75
Bearish
UltimateOscillator
45.32
Neutral
Williams Indicator
-57.28
Neutral
CCI Indicator
-0.58
Neutral
MACD
-1,869.54
Bearish
Stochastic Indicator
49.01
Neutral
ATR
53.01
High Volatility
Corporate Actions
![]()
Corporate Actions - Board Meet
Corporate Actions - Board Meet | Ex-Date | Ratio | Record Date |
|---|
| Ex-Date | Ratio | Record Date |
|---|---|---|
| Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
|---|---|---|---|
| 21-07-2023 | 8.50 | 425 | Final |
| 08-08-2022 | 5.00 | 250 | Final |
| 09-08-2021 | 5.00 | 250 | Final |
| Date Of Conduct | Board Meeting Details |
|---|---|
| 29-10-2024 | Quarterly Results |
| 10-05-2024 | Audited Results & Final Dividend |
| 25-01-2024 | Quarterly Results |
| 22-01-2024 | Quarterly Results (Revised) |
| 27-10-2023 | Quarterly Results |
| 26-07-2023 | Quarterly Results |
| 12-05-2023 | Audited Results & Quarterly Results & Final Dividend |
| 25-01-2023 | Quarterly Results |
| 04-11-2022 | Quarterly Results |
| 29-07-2022 | Quarterly Results |
| 10-05-2022 | Dividend & Audited Results |
| 25-01-2022 | Quarterly Results |
| 26-10-2021 | Quarterly Results |
| 05-08-2021 | Quarterly Results |
| 14-05-2021 | Dividend & Audited Results |